Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2023 06:05 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

SEATTLE, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
February 21, 2023 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
January 26, 2023 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will...
January 26, 2023 07:45 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Expands to San Diego

SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
January 19, 2023 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

SEATTLE, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, and the Translational...
November 16, 2022 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Launches “First Access Challenge”

SEATTLE, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
November 01, 2022 06:05 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

SEATTLE, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
October 05, 2022 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022

SEATTLE, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
September 23, 2022 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

SEATTLE, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
September 01, 2022 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

SEATTLE, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...